Development of Assaying Plasma TDP-43 Utilizing Immunomagnetic Reduction

Development of Assaying Plasma TDP-43 Utilizing Immunomagnetic Reduction - Yang et al. 2020

Development of Assaying Plasma TDP-43 Utilizing Immunomagnetic Reduction

© 2020 Yang, Liu, Lin, Chiu, Chen, Lin and Chen

Previous
Previous

Neurofilament light chain level in plasma extracellular vesicles and Parkinson’s disease

Next
Next

Immunomagnetic Reduction Detects Plasma Aβ1–42 Levels as a Potential Dominant Indicator Predicting Cognitive Decline